We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Allergan plc | NYSE:AGN | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 193.02 | 0 | 01:00:00 |
TIDM0QCV TIDM0Y7T FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) State Street Global Advisors & Affiliates --------------------------------------------- ------------------------------- Company dealt in AbbVie Inc. --------------------------------------------- ------------------------------- Class of relevant security to which US$0.01 common stock the dealings being disclosed relate (Note 2) --------------------------------------------- ------------------------------- Date of dealing 03(rd) April 2020 --------------------------------------------- ------------------------------- 2. INTERESTS AND SHORT POSITIONS (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short ------------------------------------- -------------------- ----------- Number (%) Number (%) ------------------------------------- ---------- -------- ------ --- (1) Relevant securities 68,686,698 4.65144% ------------------------------------- ---------- -------- ------ --- (2) Derivatives (other than options) N/A ------------------------------------- ---------- -------- ------ --- (3) Options and agreements to purchase/sell N/A ------------------------------------- ---------- -------- ------ --- Total 68,686,698 4.65144% ------------------------------------- ---------- -------- ------ --- (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short ------------------------------------------- ----------- ----------- Number (%) Number (%) ------------------------------------------- ------ --- ------ --- (1) Relevant securities N/A ------------------------------------------- ------ --- ------ --- (2) Derivatives (other than options) N/A ------------------------------------------- ------ --- ------ --- (3) Options and agreements to purchase/sell N/A ------------------------------------------- ------ --- ------ --- Total N/A ------------------------------------------- ------ --- ------ --- 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of relevant securities Price per unit (Note 5) -------------- ----------------------------- ----------------------- Purchase 49,700 74.55 -------------- ----------------------------- ----------------------- Purchase 551 73.37 -------------- ----------------------------- ----------------------- Purchase 4,251 73.37 -------------- ----------------------------- ----------------------- Purchase 12,000 73.37 -------------- ----------------------------- ----------------------- Purchase 46 73.37 -------------- ----------------------------- ----------------------- Purchase 400 73.37 -------------- ----------------------------- ----------------------- Purchase 2,796 73.37 -------------- ----------------------------- ----------------------- Purchase 596 73.37 -------------- ----------------------------- ----------------------- Purchase 71,120 73.37 -------------- ----------------------------- ----------------------- Purchase 928 73.37 -------------- ----------------------------- ----------------------- Purchase 1,152 73.37 -------------- ----------------------------- ----------------------- Purchase 2,688 73.37 -------------- ----------------------------- ----------------------- Purchase 624 73.37 -------------- ----------------------------- ----------------------- Purchase 5,248 73.37 -------------- ----------------------------- ----------------------- Purchase 500 73.37 -------------- ----------------------------- ----------------------- Purchase 353 73.37 -------------- ----------------------------- ----------------------- Purchase 534 73.37 -------------- ----------------------------- ----------------------- Purchase 488 73.37 -------------- ----------------------------- ----------------------- Sale 800 73.42 -------------- ----------------------------- ----------------------- Sale 96 75.13 -------------- ----------------------------- ----------------------- Sale 1,000 73.37 -------------- ----------------------------- ----------------------- Sale 12,810 75.13 -------------- ----------------------------- ----------------------- Sale 12,000 73.37 -------------- ----------------------------- ----------------------- Sale 600 73.37 -------------- ----------------------------- ----------------------- Sale 30,226 73.37 -------------- ----------------------------- ----------------------- Sale 29,820 73.37 -------------- ----------------------------- ----------------------- Sale 464 73.37 -------------- ----------------------------- ----------------------- Sale 600 73.37 -------------- ----------------------------- ----------------------- Sale 25,281 73.37 -------------- ----------------------------- ----------------------- Sale 3,762 73.37 -------------- ----------------------------- ----------------------- Sale 13,203 73.37 -------------- ----------------------------- ----------------------- Sale 400 73.37 -------------- ----------------------------- ----------------------- Sale 344 73.37 -------------- ----------------------------- ----------------------- Sale 970 73.37 -------------- ----------------------------- ----------------------- Sale 534 73.37 -------------- ----------------------------- ----------------------- Sale 267 73.37 -------------- ----------------------------- ----------------------- (b) Derivatives transactions (other than options transactions) Product name, Nature of transaction Number of relevant securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) ------------- --------------------- ----------------------------- -------------- N/A ------------- --------------------- ----------------------------- -------------- (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money e.g. call option purchasing securities to which price American, date paid/received varying etc. the option relates European etc. per unit (Note 5) (Note 7) ----------------- ----------------- -------------------- -------- -------------- ------ ------------------ N/A ----------------- ----------------- -------------------- -------- -------------- ------ ------------------ (ii) Exercising Product name, Number of securities Exercise price per e.g. call option unit (Note 5) ----------------- -------------------- ------------------ N/A ----------------- -------------------- ------------------ (d) Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) --------------------- ------- ------------------------- N/A --------------------- ------- ------------------------- 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. ----------------------------------------------------------- N/A ----------------------------------------------------------- Is a Supplemental Form 8 attached? (Note 9) NO ------------------------------------------------------- ----------------- Date of disclosure 06(th) April 2020 ------------------------------------------------------- ----------------- Contact name Lionel Colaco ------------------------------------------------------- ----------------- Telephone number 020 33956098 ------------------------------------------------------- ----------------- If a connected EFM, name of offeree/offeror with which N/A connected ------------------------------------------------------- ----------------- If a connected EFM, state nature of connection (Note N/A 10) ------------------------------------------------------- -----------------
(END) Dow Jones Newswires
April 06, 2020 12:04 ET (16:04 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions